FDA Approves METFORMIN HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma has received FDA approval for its abbreviated new drug application (ANDA) for Metformin Hydrochloride, signaling a new entry for this widely used oral diabetes treatment. Analysts anticipate the approval will diversify the company’s oral antidiabetic portfolio and provide a fresh revenue stream amidst competing generic formulations.